GL1X · GenesisL1 explorer

MolNFT v1 · #134277 · protein

Structure-based design of a new series of N-piperidin-3-ylpyrimidine- 5-carboxamides as renin inhibitors

5SZ9: “Structure-based design of a new series of N-piperidin-3-ylpyrimidine- 5-carboxamides as renin inhibitors”. X-ray diffraction, 2 ligands (74Y, NAG), 5 pockets (best druggability 0.83). MolNFT v1 #134277 on GenesisL1: 3D structure…

PDB
5SZ9
Type
protein
Length
666 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Renin
EC
3.4.23.15
UniProt
P00797
Ligands
74Y, NAG
Pockets
5 · best druggability 0.83

Structure

x-ray diffraction · 2 distinct chains · 15% helix, 45% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ARenin (EC 3.4.23.15)protein33415% helix, 46% strandP00797
BRenin (EC 3.4.23.15)protein33215% helix, 44% strandP00797

Ligands and binding sites

  • 74Y · (azepan-1-yl)(2-{[(furan-2-yl)methyl]amino}-6-methylpyridin-3-yl)methanone · ligand · 2 copies · chains A, B
  • NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · sugar · 2 copies · chains A, B
  • PEG · Di(hydroxyethyl)ether · additive · 4 copies · chains A, B
  • PGE · Triethylene glycol · additive · chains B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

5 pockets found on a 1 Å grid, 5 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
15670.830.8863PEG
26080.750.815474Y
34430.690.804274Y
42650.550.7734empty
51770.520.7924empty

Interfaces

1 interface between chains.

  • A–B · 1014 Ų buried · 16 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 6 disulfide, 2 glycan (disulfide, N-glycosylation).

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.